* Viveve Medical Inc VIVE.OQ reported a quarterly adjusted
loss
of 72 cents per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 59 cents per share.
* Revenue fell 12.4% to $1.71 million from a year ago;
analysts
expected $1.71 million.
* Viveve Medical Inc's reported EPS for the quarter was a
loss
of 72 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Viveve Medical Inc shares had fallen by 26.1% this
quarter.
* The company reported a quarterly loss of $7.56 million.
* Wall Street's median 12-month price target for Viveve
Medical
Inc is $9.63
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated March 18 at 02:42 a.m. All
figures in US dollars unless otherwise stated